查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541001

2024-2032 年肠道疾病检测市场报告（按产品类型、技术、疾病类型、最终用户和地区划分）

Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球肠道疾病检测市场规模达42亿美元。胃肠道感染发病率的上升、对早期检测的认识不断提高、诊断技术的进步、对快速准确检测方法的需求不断增长以及全球对食品和水安全标准的日益关注是推动市场增长的一些因素。

肠道疾病检测市场分析：

主要市场驱动力：全球胃肠道感染盛行率不断上升是市场的主要驱动力。卫生条件差、水污染和食源性病原体等因素导致肠道疾病发生率不断上升。诊断技术的重大进步提供快速、准确的结果，进一步推动市场成长。

主要市场趋势：分子诊断的广泛采用代表了市场的主要趋势。聚合酶链反应 (PCR) 和新一代定序 (NGS) 等技术因其高灵敏度、特异性和快速週转时间而越来越受欢迎。这些先进的诊断方法能够检测多种病原体，有助于更准确、更全面的检测。

地理趋势：亚太地区是肠道疾病检测市场成长最大的地区。由于卫生条件差、医疗保健意识增强、政府疾病控制措施以及诊断技术的进步，胃肠道感染的高发病率正在推动该地区的市场成长。

竞争格局：肠道疾病检测行业的一些主要市场参与者包括 Abbott Laboratories、BD（Becton、Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、 Corisanaher Corporation）、 Coris BioConcept、DiaSorin、Meridian Bioscience Inc. 和Quest Diagnostics 等。

挑战与机会：市场面临各种挑战，包括偏远和低收入地区先进诊断设施的使用有限，阻碍了及时的疾病检测。然而，市场也面临一些机会，例如分子诊断和即时检测的进步，可以提供快速、准确的结果。

肠道疾病检测市场趋势：

胃肠道感染发生率上升

由于卫生条件差、食物和水污染以及人口密度高，肠道疾病日益流行，特别是在发展中地区，正在推动对有效诊断检测的需求。根据《印度时报》2024 年发表的一篇文章称，由于水源污染和卫生条件差，班加罗尔的胃肠道感染病例增加。儿童有因腹泻而脱水的风险，强调 ORS 的重要性并在感染期间避免牛奶。据世界卫生组织称，全世界约有 150 万人死于腹泻。生活在发展中国家的 5 岁以下儿童尤其容易因营养不良而受到腹泻和呕吐等疾病的影响，甚至死亡。这进一步显着提升了肠道疾病检测市场价值。

不断增长的政府措施和法规

新兴的政府和卫生组织正在实施严格的食品和水安全标准，并投资公共卫生基础设施。这进一步增加了对定期和可靠的肠道疾病检测的需求，以防止疫情爆发并确保公共安全，这进一步促进了市场的成长。例如，2024 年 4 月，印度食品安全和标准局 (FSSAI) 与德里食品安全部门合作，针对国家首都的主要市场启动了一项广泛的意识和宣传计划。同样，莫迪政府的一项关键计划「国家卫生使命」（NHM）专注于改善医疗基础设施、提供基本药物和诊断以及加强基层人力资源能力。这些措施旨在减少患者在当地以外寻求昂贵治疗的需要，这进一步推动了未来几年肠道疾病检测市场的预测。

诊断技术的重大进步

包括聚合酶炼式反应（PCR）和下一代定序（NGS）在内的分子诊断领域不断创新，可提供快速、准确和全面的肠道病原体检测，从而推动了市场成长。例如，2023 年 8 月，ArcticZymes Technologies (AZT) 宣布推出新产品 AZtaq(TM) DNA 聚合酶。 AZtaq(TM) 是一种高品质热稳定性 DNA 聚合酶，适用于聚合酶炼式反应 (PCR) 应用。 AZtaq(TM) 的推出是公司分子工具产品组合的自然扩展。作为 PCR 中的必需酶，热稳定性 DNA 聚合酶发挥关键作用，并在分子诊断和研究中实现了许多应用。这进一步推动了全球肠道疾病检测市场的收入。

肠道疾病检测市场区隔：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品类型、技术、疾病类型和最终用户对市场进行了分类。

按产品类型划分：

试剂及耗材

装置

该报告根据产品类型对市场进行了详细的细分和分析。这包括试剂和消耗品以及设备。

市场对试剂和耗材的需求是由对准确、高效的诊断过程的需求所驱动的。频繁检测胃肠道病原体需要持续供应高品质的试剂和耗材。此外，传染病病率的上升，加上分子和快速检测方法的进步，需要使用专门的耗材。政府资金的增加和医疗保健基础设施的发展进一步增加了对这些基本测试组件的需求。

自动PCR系统和下一代定序平台等诊断机械的技术进步进一步推动了肠道疾病检测市场报告中对设备的需求。对高通量、可靠且精确的诊断工具的需求推动了先进设备的采用。扩大医疗保健基础设施（特别是在新兴市场）以及增加对实验室现代化的投资也有助于不断增长的需求。加强的疾病监测计画和公共卫生措施进一步刺激了诊断设备市场。

依技术分解：

分子诊断

免疫诊断

分子诊断占产业最大份额

报告还提供了基于该技术的详细市场细分和分析。这包括分子诊断和免疫诊断。报告称，分子诊断占据了最大的肠道疾病检测市场。

市场对分子诊断技术的需求是由其高精度、灵敏度和快速週转时间所推动的。 PCR 和新一代定序等技术可以精确识别多种病原体，进而改善疾病管理和疫情控制。例如，2023 年 11 月，罗氏宣布推出 LightCycler(R) PRO 系统，该系统基于先前的 LightCycler(R) 系统经过验证的黄金标准技术。这个新系统提高了性能和可用性的标准，同时缩小了转化研究和体外诊断之间的差距。 LightCycler PRO 系统进一步补充了罗氏的分子 PCR 检测产品组合，其中包括为各种医疗保健专业人员提供的解决方案 - 从进行研究的人员到对患者进行癌症、传染病和其他公共卫生挑战测试的人员。这进一步推动了全球肠道疾病检测的需求。

按疾病类型细分：

细菌性肠道疾病

艰难梭菌

弯曲菌病

霍乱

大肠桿菌

幽门螺旋桿菌

沙门氏菌病

志贺菌症

病毒性肠疾病

轮状病毒

诺罗病毒

其他的

寄生虫性肠道疾病

阿米巴病

隐孢子虫病

贾第鞭毛虫病

细菌性肠道疾病占业界最大份额

该报告根据疾病类型对市场进行了详细的细分和分析。这包括细菌性肠道疾病（艰难梭菌、弯曲桿菌病、霍乱、大肠桿菌、幽门螺旋桿菌、沙门氏菌病和志贺氏菌病）、病毒性肠道疾病（轮状病毒、诺罗病毒等）和寄生虫性肠道疾病（阿米巴病、隐孢子虫病和贾第虫病）。报告称，细菌性肠道疾病占最大的市场份额。

艰难梭菌、大肠桿菌和沙门氏菌等感染的高流行推动了对细菌类型肠道疾病检测的需求，这些感染构成了重大的公共卫生风险。快速、准确的诊断对于有效治疗、疫情管理和感染控制至关重要。幽门螺旋桿菌与严重胃肠道疾病的关联也刺激了检测需求。食源性和水源性疫情的增加、严格的食品安全法规以及对有效医疗干预措施的需求进一步推动了细菌性肠道疾病检测市场的发展。

按最终用户划分：

医院诊断实验室

独立诊断实验室

学术及研究机构

其他的

报告还提供了基于最终用户的详细市场细分和分析。这包括医院诊断实验室、独立诊断实验室、学术和研究机构等。

在医院诊断实验室中，对肠道疾病检测的需求是由于需要及时、准确的诊断来确保有效的患者管理和治疗。大量患者和诊断胃肠道感染的关键性质需要可靠和有效的测试方案。

独立诊断实验室因其专业服务和提供快速、大容量检测的能力而看到了需求。它们在常规筛检、疫情管理和提供先进的诊断技术、满足医疗保健提供者和患者的需求方面发挥着至关重要的作用。这进一步创造了积极的肠道疾病检测市场前景。

在学术和研究机构中，需求是由对肠道病原体研究、开发创新诊断方法和进行流行病学研究的关注所驱动的。传染病研究资金和补助金的增加增强了对全面和精确检测能力的需求，支持科学进步和公共卫生措施。

按地区划分：

北美洲

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

亚太地区引领市场，占据最大肠道疾病检测市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，亚太地区是肠道疾病检测的最大市场。

由于环境卫生和卫生条件差，胃肠道感染的发生率不断上升，推动了亚太地区肠道疾病检测市场的发展。全球肠道多中心研究 (GEMS) 关于发展中国家儿童腹泻负担和病因的最新资料显示，轮状病毒、隐孢子虫属、产肠毒素大肠桿菌 (ETEC) 和志贺氏菌属。是腹泻病和死亡的主要原因。此外，诺罗病毒感染是食源性疾病爆发的主要原因，与约 20% 的腹泻病例有关，儿童和成人的盛行率相似。因此，人们对健康问题的认识不断增强、政府加强疾病控制措施以及医疗保健基础设施的改善也刺激了需求。诊断技术的进步以及食品和水源性疾病盛行率的上升进一步推动了市场的成长。快速的城市化和不断扩大的中产阶级人口基数，以及更多的医疗保健机会，正在促进市场的成长。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。肠道疾病检测产业的一些主要市场参与者包括 Abbott Laboratories、BD（Becton、Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、Coris BioConcept、 DiaSorin 、Meridian Bioscience Inc. 和Quest Diagnostics。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

肠道疾病检测市场的竞争格局非常激烈，主要参与者包括 Abbott Laboratories、Thermo Fisher Scientific、Bio-Rad Laboratories 和 Becton, Dickinson and Company。这些企业专注于开发先进的诊断技术，包括分子诊断和快速检测试剂盒，以提高检测的准确性和速度。例如，2023 年 7 月，Thermo Fisher Scientific 推出了 Diomni Enterprise Software，帮助简化常规诊断测试，实现标准化并加快获得结果的速度，以应对容易出错的手动分子测试工作流程的挑战。透过在一个介面内连接工作流程步骤，Diomni Enterprise 可以提高实验室动态回应当今快速变化的测试环境的能力。

肠道疾病检测市场新闻：

2023 年 3 月，Biomerica, Inc. 宣布推出 InFoods(R) IBS 测试。该测试在 CLIA 认证和 CAP 认可的高复杂性实验室设施中进行，并作为实验室开发的测试 (LDT) 提供。该公司进一步宣布，以 LDT 形式提供 InFoods IBS 产品所需的所有验证测试均已完成。第一批患者样本已经处理完毕。

2022 年10 月，科学领域的全球领导者赛默飞世尔科技(Thermo Fisher Scientific) 宣布推出TaqPath 肠道细菌选择检测试剂盒，这是一款经过CE-IVD 标记的检测试剂盒，旨在检测常见胃肠道(GI) 细菌，帮助临床医生识别肠道细菌。该面板于 2022 年 5 月通过了 IVDD 验证并註册。

本报告回答的关键问题：

  • 迄今为止，全球肠道疾病检测市场表现如何，未来几年将如何表现？
  • 全球肠道疾病检测市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球肠道疾病检测市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的肠道疾病检测市场？
  • 依产品类型分類的市场是怎么样的？
  • 肠道疾病检测市场最具吸引力的产品类型是什么？
  • 基于技术的市场区隔是什么？
  • 肠道疾病检测市场中哪种技术最具吸引力？
  • 根据疾病类型的市场划分是怎样的？
  • 肠道疾病检测市场中哪种疾病类型最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 肠道疾病检测市场中哪一个对最终用户最具吸引力？
  • 市场竞争结构如何？
  • 全球肠道疾病检测市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球肠道疾病检测市场表现如何，未来几年将如何表现？
  • 全球肠道疾病检测市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球肠道疾病检测市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的肠道疾病检测市场？
  • 依产品类型分類的市场是怎么样的？
  • 肠道疾病检测市场最具吸引力的产品类型是什么？
  • 基于技术的市场区隔是什么？
  • 肠道疾病检测市场中哪种技术最具吸引力？
  • 根据疾病类型的市场划分是怎样的？
  • 肠道疾病检测市场最有吸引力的疾病类型是什么？
  • 基于最终用户的市场区隔是什么？
  • 肠道疾病检测市场中哪一个对最终用户最具吸引力？
  • 市场竞争结构如何？
  • 全球肠道疾病检测市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肠道疾病检测市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 试剂及耗材
    • 市场趋势
    • 市场预测
  • 装置
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • 分子诊断
    • 市场趋势
    • 市场预测
  • 免疫诊断
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依疾病类型

  • 细菌性肠道疾病
    • 市场趋势
    • 主要类型
      • 艰难梭菌
      • 弯曲菌病
      • 霍乱
      • 大肠桿菌
      • 幽门螺旋桿菌
      • 沙门氏菌病
      • 志贺菌症
    • 市场预测
  • 病毒性肠疾病
    • 市场趋势
    • 主要类型
      • 轮状病毒
      • 诺罗病毒
      • 其他的
    • 市场预测
  • 寄生虫性肠道疾病
    • 市场趋势
    • 主要类型
      • 阿米巴病
      • 隐孢子虫病
      • 贾第鞭毛虫病
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院诊断实验室
    • 市场趋势
    • 市场预测
  • 独立诊断实验室
    • 市场趋势
    • 市场预测
  • 学术及研究机构
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • BD (Becton, Dickinson and Company)
    • Bio-Rad Laboratories Inc.
    • Biomerica Inc.
    • Biomerieux SA
    • Cepheid Inc. (Danaher Corporation)
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience Inc.
    • Quest Diagnostics
Product Code: SR112024A2544

The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The rising incidences of gastrointestinal infections, increasing awareness about the early detection, advancements in diagnostic technologies, the growing demand for rapid and accurate testing methods, and rising global focus on food and water safety standards are some of the factors propelling the growth of the market.

Enteric Disease Testing Market Analysis:

Major Market Drivers: The rising prevalence of gastrointestinal infections across the globe represents the major driver of the market. Factors including poor sanitation, contaminated water, and foodborne pathogens contribute to the increasing incidence of enteric diseases. Significant advancements in diagnostic technologies offering rapid and accurate results further driving the market growth.

Key Market Trends: The widespread adoption of molecular diagnostics represents the key trends in the market. Techniques including polymerase chain reaction (PCR) and next-generation sequencing (NGS) are gaining popularity due to their high sensitivity, specificity, and rapid turnaround time. These advanced diagnostic methods enable the detection of a wide range of pathogens, contributing to more accurate and comprehensive testing.

Geographical Trends: Asia Pacific accounts for the largest region in the enteric disease testing market growth. The high incidence of gastrointestinal infections is driving the market growth across the region due to poor sanitation, increasing healthcare awareness, government initiatives for disease control, and advancements in diagnostic technologies.

Competitive Landscape: Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics, among many others.

Challenges and Opportunities: The market faces various challenges including limited access to advanced diagnostic facilities in remote and low-income regions, which hampers timely disease detection. However, the market also faces several opportunities such as advancements in molecular diagnostics and point-of-care testing which offer rapid and accurate results.

Enteric Disease Testing Market Trends:

Rising Incidence of Gastrointestinal Infections

The growing prevalence of enteric diseases due to poor sanitation, contaminated food and water, and high population density, especially in developing regions, is driving the demand for effective diagnostic testing. According to an article published by the Times of India in 2024, Bengaluru witnesses a rise in gastrointestinal infections attributed to contaminated water sources and poor sanitation. Children are at risk of dehydration due to diarrhea, emphasizing the importance of ORS and avoiding milk during infections. According to the WHO, approximately 1.5 million people worldwide die of diarrheal disease alone. Children under the age of 5 living in developing countries are particularly affected by conditions such as diarrhea and vomiting through malnutrition and death. This is further boosting the enteric disease testing market value significantly.

Growing Government Initiatives and Regulations

The rising government and health organizations are implementing strict food and water safety standards and investing in public health infrastructure. This further increases the need for regular and reliable enteric disease testing to prevent outbreaks and ensure public safety which is further contributing to the growth of the market. For instance, in April 2024, The Food Safety and Standards Authority of India (FSSAI) launched an extensive awareness and sensitization program targeting major markets in the national capital, in collaboration with the Food Safety Department, Delhi. Similarly, the National Health Mission (NHM), a key program under the Modi government, focuses on improving healthcare infrastructure, providing essential drugs and diagnostics, and strengthening human resource capabilities at the grassroots level. These initiatives are aimed at reducing the need for patients to seek expensive treatments outside their localities which is further boosting the enteric disease testing market forecast over the coming years.

Significant Advancements in Diagnostic Technologies

The increasing innovation in molecular diagnostics including polymerase chain reaction (PCR) and next-generation sequencing (NGS), provide rapid, accurate, and comprehensive detection of enteric pathogens, which is boosting the market growth. For instance, in August 2023, ArcticZymes Technologies (AZT) announced the launch of its new product, AZtaq(TM) DNA Polymerase. AZtaq(TM) is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launched the AZtaq(TM) is a natural expansion of the Company's molecular tools portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase plays a pivotal role and enables numerous applications within molecular diagnostics and research. This is further driving the enteric disease testing market revenue across the globe.

Enteric Disease Testing Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, technique, disease type, and end user.

Breakup by Product Type:

Reagents and Consumables

Equipment

The report has provided a detailed breakup and analysis of the market based on the product type. This includes reagents and consumables, and equipment.

The demand for reagents and consumables in the market is driven by the need for accurate and efficient diagnostic processes. Frequent testing for gastrointestinal pathogens requires a constant supply of high-quality reagents and consumables. Additionally, the rise in infectious disease prevalence, coupled with advancements in molecular and rapid testing methods, necessitates the use of specialized consumables. Increased government funding and healthcare infrastructure development further boost demand for these essential testing components.

Technological advancements in diagnostic machinery, such as automated PCR systems and next-generation sequencing platforms are further driving the demand for equipment in the enteric disease testing market report. The need for high-throughput, reliable, and precise diagnostic tools drive the adoption of advanced equipment. Expanding healthcare infrastructure, particularly in emerging markets, and increased investment in laboratory modernization also contribute to the growing demand. Enhanced disease surveillance programs and public health initiatives further stimulate the market for diagnostic equipment.

Breakup by Technique:

Molecular Diagnostics

Immunodiagnostics

Molecular diagnostics holds the largest share of the industry

A detailed breakup and analysis of the market based on the technique have also been provided in the report. This includes molecular diagnostics and immunodiagnostics. According to the report, molecular diagnostics accounted for the largest enteric disease testing market share.

The demand for molecular diagnostics techniques in the market is driven by their high accuracy, sensitivity, and rapid turnaround times. These techniques, such as PCR and next-generation sequencing, enable precise identification of a wide range of pathogens, improving disease management and outbreak control. For instance, in November 2023, Roche announced the launch of the LightCycler(R) PRO System based on the proven gold standard technology of the LightCycler(R) Systems that came before it. This new system raises the bar for performance and usability while bridging the gap between translational research and in vitro diagnostics. The LightCycler PRO System further complements Roche's molecular PCR testing portfolio, which includes solutions for a variety of healthcare professionals - from those performing research to those testing patients for cancer, infectious diseases, and other public health challenges. This is further driving the enteric disease testing demand across the globe.

Breakup by Disease Type:

Bacterial Enteric Disease

C. Difficile

Campylobacteriosis

Cholera

E. Coli

H. Pylori

Salmonellosis

Shigellosis

Viral Enteric Disease

Rotavirus

Norovirus

Others

Parasitic Enteric Disease

Amebiasis

Cryptosporidiosis

Giardiasis

Bacterial enteric disease holds the largest share of the industry

The report has provided a detailed breakup and analysis of the market based on the disease type. This includes Bacterial Enteric Disease (C. Difficile, Campylobacteriosis, Cholera, E. Coli, H. Pylori, Salmonellosis, and Shigellosis), Viral Enteric Disease (Rotavirus, Norovirus, and Others), and Parasitic Enteric Disease (Amebiasis, Cryptosporidiosis, and Giardiasis). According to the report, Bacterial Enteric Disease accounted for the largest market share.

The demand for enteric disease testing in bacterial types is driven by the high prevalence of infections like C. difficile, E. coli, and Salmonellosis, which pose significant public health risks. Rapid, accurate diagnostics are crucial for effective treatment, outbreak management, and infection control. The association of H. pylori with severe gastrointestinal conditions also fuels testing demand. Increasing foodborne and waterborne outbreaks, stringent food safety regulations, and the need for efficient healthcare interventions further boost the market for bacterial enteric disease testing.

Breakup by End User:

Hospital Diagnostic Laboratories

Independent Diagnostic Laboratories

Academic and Research Institutes

Others

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.

In hospital diagnostic laboratories, the demand for enteric disease testing is driven by the necessity for prompt and accurate diagnosis to ensure effective patient management and treatment. High patient volumes and the critical nature of diagnosing gastrointestinal infections necessitate reliable and efficient testing protocols.

Independent diagnostic laboratories see demand due to their specialized services and ability to provide rapid, high-volume testing. They play a crucial role in routine screening, outbreak management, and offering advanced diagnostic techniques, meeting the needs of both healthcare providers and patients. This is further creating a positive enteric disease testing market outlook.

In academic and research institutes, demand is driven by the focus on studying enteric pathogens, developing innovative diagnostic methods, and conducting epidemiological research. Increased funding and grants for infectious disease research enhance the need for comprehensive and precise testing capabilities, supporting scientific advancements and public health initiatives.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest enteric disease testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest market for enteric disease testing.

The market for enteric disease testing in Asia Pacific is driven by the increasing incidence rates of gastrointestinal infections due to poor sanitation and hygiene. Recent data from the Global Enteric Multicenter Study (GEMS) on the burden and etiology of diarrhea among children residing in developing countries showed that rotavirus, Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella spp. are the major causes of diarrheal diseases and death. Furthermore, norovirus infections are the principal cause of foodborne disease outbreaks and are associated with approximately 20% of diarrhea cases, with similar prevalence in both children and adults. Consequently, the growing awareness of health issues, increased government initiatives for disease control, and improvements in healthcare infrastructure also boost demand. Advancements in diagnostic technologies and the rising prevalence of food and waterborne diseases further propel the market growth. Rapid urbanization and the expanding middle class population base, with greater access to healthcare, are contributing to the market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The competitive landscape of the enteric disease testing market is highly competitive with key players such as Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, and Becton, Dickinson and Company. These players focus on developing advanced diagnostic technologies, including molecular diagnostics and rapid testing kits, to enhance detection accuracy and speed. For instance, in July 2023, Thermo Fisher Scientific introduced Diomni Enterprise Software, helping streamline routine diagnostics testing for standardization and faster time-to-results to address challenges with error-prone, manual molecular testing workflows. By connecting workflow steps within one interface, Diomni Enterprise can increase a lab's ability to dynamically respond to today's rapidly changing testing environment.

Enteric Disease Testing Market News:

In March 2023, Biomerica, Inc. announced the launch of its InFoods(R) IBS test. The test is being performed in a CLIA-certified, and CAP-accredited high-complexity laboratory facility and offered as a laboratory-developed test (LDT). The Company further announced all validation testing necessary for the InFoods IBS product to be offered as an LDT has been completed. The first patient samples have been processed.

In October 2022, Thermo Fisher Scientific, the world leader in the field of science, announced the launch of the TaqPath Enteric Bacterial Select Panel, a CE-IVD marked panel designed to detect common gastrointestinal (GI) bacteria and help enable clinicians to identify the root cause of an infection and administer the most appropriate treatment to their patients more quickly. The panel was validated and registered under IVDD in May 2022.

Key Questions Answered in This Report:

  • How has the global enteric disease testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global enteric disease testing market?
  • What is the impact of each driver, restraint, and opportunity on the global enteric disease testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive enteric disease testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the enteric disease testing market?
  • What is the breakup of the market based on the technique?
  • Which is the most attractive technique in the enteric disease testing market?
  • What is the breakup of the market based on the disease type?
  • Which is the most attractive disease type in the enteric disease testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the enteric disease testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global enteric disease testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technique

  • 7.1 Molecular Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunodiagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Bacterial Enteric Disease
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 C. Difficile
      • 8.1.2.2 Campylobacteriosis
      • 8.1.2.3 Cholera
      • 8.1.2.4 E. Coli
      • 8.1.2.5 H. Pylori
      • 8.1.2.6 Salmonellosis
      • 8.1.2.7 Shigellosis
    • 8.1.3 Market Forecast
  • 8.2 Viral Enteric Disease
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Rotavirus
      • 8.2.2.2 Norovirus
      • 8.2.2.3 Others
    • 8.2.3 Market Forecast
  • 8.3 Parasitic Enteric Disease
    • 8.3.1 Market Trends
    • 8.3.2 Major Types
      • 8.3.2.1 Amebiasis
      • 8.3.2.2 Cryptosporidiosis
      • 8.3.2.3 Giardiasis
    • 8.3.3 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Independent Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BD (Becton, Dickinson and Company)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerica Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biomerieux SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cepheid Inc. (Danaher Corporation)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Coris BioConcept
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 DiaSorin
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meridian Bioscience Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quest Diagnostics
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2023
  • Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2023
  • Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
  • Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
  • Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Enteric Disease Testing Market Structure
  • Table 8: Global: Enteric Disease Testing Market: Key Players